Nina Capital Invests in Woodway Assurance to Combat Health Data Challenges

In a significant development in the health technology sector, Nina Capital, a renowned international venture capital firm, has announced its investment in the Canadian company Woodway Assurance. This move signifies the escalating demand for innovative privacy-enhancing solutions in health data management, a field where Woodway's flagship product, EviData™, plays a critical role.

Understanding the Need for EviData™

Healthcare organizations often grapple with vast amounts of sensitive data that can be pivotal for research and AI applications. However, concerns regarding data privacy and regulatory constraints frequently stall projects, leaving valuable insights untapped. EviData™ addresses these challenges by offering an automated, AI-driven workflow that not only assesses privacy risks across structured and unstructured data but also implements privacy-preserving transformations.

Marta G. Zanchi, the founding managing partner at Nina Capital, emphasizes the importance of responsible data usage, stating, "Data is essential for research, AI, and improving patient care. However, necessary privacy and regulatory concerns, as well as complex operational challenges, often prevent organizations from leveraging it fully." This observation highlights the critical gaps that Woodway Assurance seeks to bridge with its EviData technology.

Achievements of Woodway Assurance

Woodway Assurance has demonstrated substantial momentum leading up to this investment. The launch of EviData™ 3.0 and the establishment of strategic partnerships illustrate the company's growing influence in the health tech landscape. With Nina Capital's backing, Woodway is poised to further enhance its product offerings, expand commercial operations, and penetrate new international markets.

Dr. Khaled El Emam, the CEO of Woodway Assurance, expressed enthusiasm about the partnership: "Nina Capital's backing is an important endorsement of our approach to solving one of the biggest barriers to responsible data use. Together, we can bring EviData™ to more organizations that need faster, scalable and defensible ways to leverage data."

EviData™: A Solution to Privacy Concerns

The core advantage of EviData™ lies in its ability to provide objective evidence aligned with international standards, such as the ISO de-identification standards and GDPR regulations. This positions organizations to proceed with their data-driven initiatives confidently, armed with the knowledge that they are adhering to stringent privacy guidelines.

The EviData™ platform not only assesses data but also generates actionable insights that facilitate decision-making across business, technical, privacy, legal, and governance teams. This capability is especially vital as organizations seek to innovate in clinical practices while navigating a complex web of regulatory requirements.

Investment Significance and Future Directions

Nina Capital's investment builds on Woodway's previous financial milestones, including a noteworthy $1 million CAD seed funding round announced in December 2025. As Woodway Assurance advances its technology and expands its client base, the profound expertise and network provided by Nina Capital are expected to catalyze significant growth and innovation.

Indeed, Ninа Cаpitаl's focus on transformative healthcare technology aligns perfectly with Woodway’s trajectory. With its deep roots in health data and technology sectors, Nina is uniquely equipped to support Woodway's mission of reducing barriers to data usage while enhancing privacy measures.

Conclusion

As the healthcare industry increasingly turns towards data-driven innovations, partnerships like that between Nina Capital and Woodway Assurance signal a promising future for privacy-centric health technology solutions. With evolving platforms like EviData™, organizations can look forward to unlocking the full potential of their data in a manner that respects privacy and enhances patient care. Together, Nina Capital and Woodway Assurance are set to drive impactful change in the healthcare landscape, addressing the pressing need for responsible data usage in clinical settings